GSK logo

GSK
Glaxosmithkline plc - ADR

9,515
Mkt Cap
$104.21B
Volume
3.09M
52W High
$61.70
52W Low
$32.38
PE Ratio
14.01
GSK Fundamentals
Price
$52.41
Prev Close
$52.06
Open
$51.76
50D MA
$54.52
Beta
0.27
Avg. Volume
6.95M
EPS (Annual)
$3.72
P/B
4.74
Rev/Employee
$644,088.53
$119,635.62
Loading...
Loading...
News
all
press releases
Here's Why GSK (GSK) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks·6h ago
News Placeholder
More News
News Placeholder
Federal Judge Flags Legal Flaws In RFK Jr.'s Vaccine Overhaul
A federal judge warns that RFK Jr.'s vaccine overhaul likely violates federal law. Discover the latest on the ACIP legal challenge here.read more...
Benzinga·2d ago
News Placeholder
GSK PLC Sponsored ADR (NYSE:GSK) Short Interest Update
GSK PLC Sponsored ADR (NYSE:GSK - Get Free Report) was the target of a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling...
MarketBeat·3d ago
News Placeholder
GSK's RSV Vaccine Arexvy Wins FDA Nod for High-Risk Younger Adults
GSK secures FDA approval to expand Arexvy's use to high-risk adults aged 18-49 years, broadening access as the company pushes wider global adoption.
Zacks·3d ago
News Placeholder
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report
Amgen Inc. (NASDAQ: AMGN) and GSK plc (NYSE: GSK) are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer substantial discounts on prescription...
Benzinga·3d ago
News Placeholder
GSK plc (LON:GSK) Receives Consensus Recommendation of "Hold" from Analysts
GSK plc (LON:GSK - Get Free Report) has been assigned an average recommendation of "Hold" from the seven analysts that are covering the firm, Marketbeat reports. One research analyst has rated the...
MarketBeat·5d ago
News Placeholder
Two major drug companies are the latest to join TrumpRx
Exclusive: The White House is expecting to announce an expansion of the drugmakers offering discounts on TrumpRx.gov, FOX Business has learned.As early as today, Amgen and GSK will be added to the...
FOXBusiness.com - Business/Financial·6d ago
News Placeholder
GSKs RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 1849 Years at Increased Risk
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults...
Business Wire·6d ago
News Placeholder
AnaptysBio Details First Tracks Bio Spin-Off, Jemperli Royalty Surge and GSK Litigation Timeline
AnaptysBio (NASDAQ:ANAB) CEO Daniel Faga outlined progress on the company's planned separation into two entities, provided an update on its royalty streams and ongoing litigation related to GSK's...
MarketBeat·8d ago
News Placeholder
Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production
Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production Myriad Venture Partners Expands Executive Advisory Board as Enterprise AI Moves Into Production PR...
PR Newswire·8d ago
<
1
2
...
>

Latest GSK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.